https://investors.vib.be/ daily 0.9 https://investors.vib.be/animab-secures-eur-10-million-in-series-b-financing-to-launch-nanoprotecr-in-europe-and-expand-pipeline weekly 0.7 https://investors.vib.be/spica-therapeutics-closes-10-million-seed-round-to-advance-macrophage-targeted-therapies weekly 0.7 https://investors.vib.be/lever-bio-announces-a-4-million-financing-round-and-a-strategic-partnership-with-vib-to-advance-four-novel-immuno-oncology-assets weekly 0.7 https://investors.vib.be/orionis-biosciences-announces-strategic-partnership-with-genentech-to-discover-and-develop-molecular-glue-class-medicines-for-cancer weekly 0.7 https://investors.vib.be/vib-launches-new-agtech-spin-off-rainbow-crops-to-develop-climate-resilient-crop-varieties weekly 0.7 https://investors.vib.be/vib-delivers-12-fold-economic-return-to-flanders-independent-study-confirms weekly 0.7 https://investors.vib.be/animab-enters-into-an-exclusive-distribution-agreement-with-huvepharma-to-commercialise-nanoprotecr-for-etec-protection-in-piglets-in-europe weekly 0.7 https://investors.vib.be/augustine-therapeutics-raises-oversubscribed-eur-78-million--usd-85-million-series-a-financing-round weekly 0.7 https://investors.vib.be/revolutionizing-protein-crop-cultivation-in-europe weekly 0.7 https://investors.vib.be/tanai-therapeutics-appoints-pieter-rottiers-as-chief-executive-officer weekly 0.7 https://investors.vib.be/vib-spin-off-muna-therapeutics-announces-strategic-alliance-with-gsk-to-accelerate-development-of-novel-treatments-for-alzheimers-disease weekly 0.7 https://investors.vib.be/vub-and-vib-launch-new-bio-incubator-brussels-on-vub-campus weekly 0.7 https://investors.vib.be/innovating-in-the-world-of-oncology-through-rna-therapeutics weekly 0.7 https://investors.vib.be/exevir-announces-michael-garrett-as-new-chief-executive-officer weekly 0.7 https://investors.vib.be/zymofix-secures-2-million-to-scale-microbial-solutions-for-sustainable-agriculture-and-beyond weekly 0.7 https://investors.vib.be/protealis-secures-12m-eur-vlaio-grants-to-advance-local-high-performing-legume-crop-innovations-in-northern-europe weekly 0.7 https://investors.vib.be/confo-therapeutics-announces-publication-in-nature-communications-demonstrating-first-ever-structure-of-a-complex-between-an-antibody-based-agonist-and-a-class-a-gpcr-regulating-hunger-and-satiety weekly 0.7 https://investors.vib.be/tanai-therapeutics-secures-additional-financing-from-novo-nordisk-and-biogeneration-ventures-for-novel-obesity-drug weekly 0.7 https://investors.vib.be/european-soy-industry-gathered-in-ghent-belgium-during-most-northern-soy-field-event weekly 0.7 https://investors.vib.be/mrm-health-a-vib-spin-off-company-appoints-gregoire-franoux-as-chief-business-officer-and-adds-ron-robison-to-its-board-of-directors weekly 0.7 https://investors.vib.be/confo-therapeutics-announces-eur-60m-series-b-financing-to-advance-pipeline-of-novel-gpcr-modulating-therapies-into-clinical-development weekly 0.7 https://investors.vib.be/protealis-a-vib-spin-off-company-appoints-frank-van-lierde-to-its-board-of-directors weekly 0.7 https://investors.vib.be/augustine-therapeutics-a-vib-spin-off-company-raises-eur-17-million-in-a-first-closing-of-series-a weekly 0.7 https://investors.vib.be/animab-announces-jan-spaas-as-new-chairman-of-the-board weekly 0.7 https://investors.vib.be/apheabio-submits-regulatory-approval-application-for-first-biofungicides weekly 0.7 https://investors.vib.be/precision-oncology-company-flindr-therapeutics-announces-20-million-series-a-financing-to-advance-first-in-class-small-molecule-inhibitors weekly 0.7 https://investors.vib.be/mrm-health-initiates-clinical-research-in-parkinsons-disease weekly 0.7 https://investors.vib.be/protealis-secures-eur-22-million-in-oversubscribed-b-round-funding-to-propel-sustainable-plant-protein-seed-solutions weekly 0.7 https://investors.vib.be/exevir-bio-announces-positive-virus-neutralization-data weekly 0.7 https://investors.vib.be/orionis-biosciences-announces-collaboration-with-genentech-to-discover-and-develop-molecular-glue-class-medicines weekly 0.7 https://investors.vib.be/mrm-health-announces-positive-phase-2a-results-in-ulcerative-colitis weekly 0.7 https://investors.vib.be/mrm-health-reports-positively-on-phase-2a-pouchitis-study weekly 0.7 https://investors.vib.be/vib-spin-off-apheabio-secures-70-million--series-c-funding weekly 0.7 https://investors.vib.be/exevir-bio-awarded-16m-grant-for-dengue-research weekly 0.7 https://investors.vib.be/vib-spin-off-dualyx-raises-40-million-to-progress-treg-therapies-for-autoimmune-diseases weekly 0.7 https://investors.vib.be/vib-spin-off-flamingo-therapeutics-merges-with-dynacure-to-create-leading-rna-therapeutics-company-in-oncology weekly 0.7 https://investors.vib.be/confo-therapeutics-to-collaborate-with-daiichi-sankyo-on-cns-diseases weekly 0.7 https://investors.vib.be/vib-spin-off-mrm-health-completes-patient-recruitment-in-ulcerative-colitis-study-secures-financing-and-provides-outlook-for-2023 weekly 0.7 https://investors.vib.be/vib-spin-off-confo-therapeutics-announces-global-licensing-agreement-with-lilly-for-peripheral-pain-candidate-cftx-1554 weekly 0.7 https://investors.vib.be/animab-raises-10-million-for-further-development-of-edible-antibodies weekly 0.7 https://investors.vib.be/exevir-bio-announces-next-generation-covid-therapy-and-looks-to-expand-activities-into-dengue-fever weekly 0.7 https://investors.vib.be/vib-spin-off-orionis-biosciences-secures-55-million-and-advances-into-clinical-trials weekly 0.7 https://investors.vib.be/confo-therapeutics-receives-17-million-vlaio-grant-for-further-research-on-gpcr-modulators-for-rare-diseases weekly 0.7 https://investors.vib.be/vib-spin-off-mrm-health-receives-approval-for-phase-2-clinical-trial-in-pouchitis weekly 0.7 https://investors.vib.be/vib-spin-off-mrm-health-reports-positive-preclinical-results-in-non-alcoholic-fatty-liver-disease weekly 0.7